News & Events

Want to see what we’ve been up to? Check out our latest news, events and press releases.

In the News

Servier and Aitia Mobilize AI and Digital Twins to Treat Pancreatic Cancer

Servier and Aitia Mobilize AI and Digital Twins to Treat Pancreatic Cancer

The French pharmaceutical group Servier and Aitia announced on May 17th a multi-year partnership agreement for the discovery and simulation of drugs in pancreatic cancer. It is based on the combination of Servier’s expertise in preclinical trials with Aitia’s technology, which is based on artificial intelligence and Gemini Digital Twins…

read more
Companies to Focus on Therapeutic Targets Showing Cause and Effect

Companies to Focus on Therapeutic Targets Showing Cause and Effect

Aitia has been featured in Huntington’s Disease News for its collaboration with UCB to develop a new treatment for Huntington’s disease. The article highlights Aitia’s expertise in Causal AI as “a new branch of artificial intelligence that goes beyond establishing links between variables: It makes decisions and predictions based on cause and effect”…

read more
UCB Enters Drug Discovery Collaboration with Aitia

UCB Enters Drug Discovery Collaboration with Aitia

Global biopharmaceutical firm UCB has entered an early drug discovery collaboration with Aitia. The collaboration is aimed at discovering and validating new drug targets and drug candidates that are linked to clinical endpoints causally in Huntington’s disease, a debilitating genetic disorder…

read more